retatrutide phase 2 diabetes trial ๐จ Today, retatrutide, the GIP/GLP-1/glucagon triple agonist, just delivered TRIUMPH-2 top-line results. A study in those with concurrent obesity and type diabetes. ๐ Mean body weight change at 80 weeks: โฌ๏ธ Retatrutide Helped Adults With Diabetes
Pay in 4 interest-free payments of $6.55 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours ยท Estimated delivery Jul 31 - Aug 5




























